Literature DB >> 14580580

Antisense technology in molecular and cellular bioengineering.

Li Kim Lee1, Charles M Roth.   

Abstract

Antisense technology is finding increasing application not only in clinical development, but also for cellular engineering. Several types of antisense methods (e.g. antisense oligonucleotides, antisense RNA and small interfering RNA) can be used to inhibit the expression of a target gene. These antisense methods are being used as part of metabolic engineering strategies to downregulate enzymes controlling undesired pathways with regard to product formation. In addition, they are beginning to be utilized to control cell phenotype in tissue engineering constructs. As improved methods for antisense effects that can be externally regulated emerge, these approaches are likely to find increased application in cellular engineering applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580580     DOI: 10.1016/s0958-1669(03)00115-0

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  15 in total

1.  Effect of antisense MBD1 gene eukaryotic expression plasmid on expression of MBD1 gene in human biliary tract carcinoma cells.

Authors:  Shi Zuo; Shengquan Zou; Jian Luo; Wei Guo; Lining Xu; Jingqing Dong; Minfeng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Oligonucleotide structure influences the interactions between cationic polymers and oligonucleotides.

Authors:  Sumati Sundaram; Sandra Viriyayuthakorn; Charles M Roth
Journal:  Biomacromolecules       Date:  2005 Nov-Dec       Impact factor: 6.988

3.  Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.

Authors:  Charles M Roth
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

4.  Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides.

Authors:  Li Kim Lee; Charity L Williams; David Devore; Charles M Roth
Journal:  Biomacromolecules       Date:  2006-05       Impact factor: 6.988

5.  A versatile transreplication-based system to identify cellular proteins involved in geminivirus replication.

Authors:  Gabriel Morilla; Araceli G Castillo; Werner Preiss; Holger Jeske; Eduardo R Bejarano
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.

Authors:  Z Qi; R Mi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

7.  Borrelia burgdorferi ftsZ plays a role in cell division.

Authors:  Lydia Dubytska; Henry P Godfrey; Felipe C Cabello
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

8.  Volatility in mRNA secondary structure as a design principle for antisense.

Authors:  Erik Johnson; Ranjan Srivastava
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

9.  New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Authors:  O A Patutina; N L Mironova; V V Vlassov; M A Zenkova
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

10.  Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity.

Authors:  Sumati Sundaram; Li Kim Lee; Charles M Roth
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.